Hasil Filter

11778

Total database: 17430
Struktur (SMILES)
8554 (72.6%)
Target
6383 (54.2%)
Genomik
96 (0.8%)
Referensi
11778 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (11778)

Halaman 49 / 236
Atropine Approved DB00572
small molecule | CAS: 51-55-8

Atropine is an alkaloid originally synthesized from Atropa belladonna. It is a racemic mixture of d-and l-hyoscyamine, of which only l-hyoscyamine is pharmacologically active.[A251670,L42835] Atropine is generally available as a sulfate salt and can be admini…

Kategori:
Adjuvants, AnesthesiaAgents producing tachycardiaAgents that produce hypertension +32
Target Protein:
Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M2Muscarinic acetylcholine receptor M3 +5
Waktu ParuhFollowing intraveno…
Vol. DistribusiAtropine is distrib…
KlirensFollowing intraveno…
Genetik -
ATSN-101 DB18327
biotech

ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5-GUCY2D)

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Attapulgite Approved DB01574
small molecule | CAS: 12174-11-7

Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States. When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it …

Kategori:
Alimentary Tract and MetabolismAntidiarrheals, Intestinal Antiinflammatory/antiinfective AgentsAntidotes +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ATU-027 DB12171
biotech | CAS: 1415935-22-6

Atu027 has been used in trials studying the treatment of Advanced Solid Tumors.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Atuliflapon DB19029
small molecule | CAS: 2041075-86-7

Atuliflapon is under investigation in clinical trial NCT05251259 (Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-severe Uncontrolled Asthma).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Atuzaginstat DB19030
small molecule | CAS: 2211981-76-7

Atuzaginstat is under investigation in clinical trial NCT03823404 (GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ATX-101 DB05780
small molecule

ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. This includes treatment of superficial lipomas (benign tumors of soft tissue composed of mature fat cells), fat d…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ATX-201 DB05765
small molecule

ATX-201 is one of a family of novel compounds that inhibits microtubule polymerization. It is developed by Kythera Biopharmaceuticals, Inc. for the treatment of actinic keratosis. The company announced the decision to discontinue its ATX-201 clinical program…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ATX-914 DB12673
small molecule

Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.).

Kategori:
Heterocyclic Compounds, Fused-RingQuinazolines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ATX-F8-117 DB17712
biotech

ATX-F8-117 is an investigational peptide derived from Factor VIII. Developed by Apitope, it is being investigated for the treatment of hemophilia A.[L46163]

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AUM-302 DB18114
small molecule | CAS: 1414455-21-2

Deskripsi belum tersedia.

Kategori:
Enzyme InhibitorsProtein Kinase InhibitorsSulfur Compounds
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AUM-601 DB17382
small molecule

AUM-601 is a highly selective pan-TRK(tropomyosin receptor kinase). It is currently being investigated in clinical trials for the treatment of cancer.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AUNP-12 DB15771
biotech | CAS: 1353563-85-5

Deskripsi belum tersedia.

Kategori:
Immune Checkpoint Inhibitors
Target Protein:
Programmed cell death 1 ligand 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Aureobasidium pullulans var. pullutans is a fungus which can provoke allergic reactions. Aureobasidium pullulans var. pullutans extract is used in allergenic testing.

Kategori:
Cell-mediated ImmunityIncreased Histamine ReleaseIncreased IgG Production +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Auriclosene DB12197
small molecule | CAS: 846056-87-9

Auriclosene has been used in trials studying the treatment of Impetigo, Bacterial Conjunctivitis, Asymptomatic Bacteriuria, and Adenoviral Conjunctivitis.

Kategori:
AlkanesAlkanesulfonic AcidsHydrocarbons, Acyclic +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Aurodox DB04124
small molecule | CAS: 12704-90-4

Aurodox is an antibiotic obtained from a streptomyces variant considered as possibly effective against streptococcus pyogenes infections. It may promote growth in poultry.

Kategori:
AlkenesAnti-Bacterial AgentsAnti-Infective Agents +2
Target Protein:
Elongation factor Tu-B
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Aurothioglucose Approved DB09121
small molecule | CAS: 12192-57-3

Aurothioglucose, also known as gold thioglucose, was formerly used to treat rheumatoid arthritis. Contemporary research on the effect of gold salts treatment began in 1935, primarily to reduce inflammation and to slow disease progression in patients with r…

Kategori:
Antiinflammatory and Antirheumatic ProductsAntirheumatic AgentsDrugs that are Mainly Renally Excreted +5
Target Protein:
Adenylate cyclase type 1Adenylate cyclase type 2Adenylate cyclase type 5
Waktu ParuhThe biological half…
Vol. DistribusiReadily accessible …
KlirensWhen a standard wee…
Genetik -
Aurotioprol DB13763
small molecule | CAS: 27279-43-2

Deskripsi belum tersedia.

Kategori:
AlcoholsAntiinflammatory and Antirheumatic ProductsAntirheumatic Agents +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AUROVERTIN B DB07394
small molecule

Deskripsi belum tersedia.

Kategori:
Pyrans
Target Protein:
ATP synthase subunit alpha, mitochondrialATP synthase subunit beta, mitochondrialATP synthase subunit gamma, mitochondrial
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AUTO3 DB17364
biotech

AUTO3 is bicistronic chimeric antigen receptor T-cell therapy investigated for acute lymphoblastic leukemia (ALL). It is an investigational chimeric antigen receptor (CAR) T cell treatment targeting CD19 and CD22.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 2365453-34-3

Autogene cevumeran is an mRNA-based cancer vaccine targeting an unspecified amount of tumour-associated antigens. It is being investigated for cancers.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Autologous cultured chrondrocytes are used as autologous cell therapy to repair articular cartilage injuries in the knee (femoral condyle) due to acute or repetitive trauma. It serves as an alternative repair treatment for patients with inadequate response to…

Kategori:
Autologous Cultured Cell
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Autologous DNP-conjugated tumour vaccine, or melanoma vaccine, is an investigational autologous cell vaccine technology for melanoma.[A254806]

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Autologous hematopoietic peripheral blood stem cells were tested in a clinical trial (NCT00424489) by Northwestern University for the treatment of refractory myasthenia gravis.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Autologous non-hematopoietic peripheral blood stem cells have been created into a formulation for use in a clinical trial (NCT04473170) by the Abu Dhabi Stem Cells Center. The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.[L16363]

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Autologous peripheral blood-derived CD34+ cells, or CLBS119 (a proprietary version being developed by Caladrius Biosciences, Inc.), are hematopoietic stem cells.[L27741] It is also a cell therapy being investigated by Caladrius Biosciences in the clinical tri…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AUY922 DB11881
small molecule | CAS: 747412-64-2

AUY922 has been used in trials studying the treatment of Lymphoma, Breast Cancer, Metastatic Disease, Advanced Solid Tumors, and Hematologic Neoplasms, among others.

Kategori:
Benzene DerivativesHSP90 Heat-Shock Proteins, antagonists & inhibitorsPhenols
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AV-101 DB12878
small molecule | CAS: 153152-32-0

AV-101 has been used in trials studying the treatment of Neuropathic Pain.

Kategori:
Amino AcidsAmino Acids, Peptides, and ProteinsSweetening Agents
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AV608 DB05072
small molecule

AV608 is a NK-1 antagonist. It is developed for the treatment of Social anxiety disorder (SAD), irritable bowel syndrome (IBS) and overactive bladder (OAB).

Target Protein:
Substance-P receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AVA-4746 DB18022
small molecule | CAS: 422268-99-3

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AVA-6000 DB17398
small molecule | CAS: 1841402-73-0

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Avacincaptad pegol Approved DB15165
biotech | CAS: 1613641-69-2

Avacincaptad pegol is an RNA aptamer covalently bound to a branched polyethylene glycol (PEG) molecule. It was developed to treat an advanced form of age-related macular degeneration (AMD) called geographic atrophy (GA).[L47696] AMD is the leading cause of vi…

Kategori:
Aptamers, NucleotideComplement Inactivating AgentsComplement Inactivator Proteins
Target Protein:
Complement C5
Waktu ParuhThe estimated appar…
Vol. DistribusiLimited information…
KlirensLimited information…
Genetik -
Avacopan Approved DB15011
small molecule | CAS: 1346623-17-3

Anti-neutrophil cytoplasmic (auto)antibody (ANCA)-associated vasculitis (AAV) is a rare (estimated incidence of 3 cases per 100,000 per year) form of "pauci-immune" systemic small-vessel vasculitis typified by the presence of ANCAs in the serum.[A240249, A240…

Kategori:
AminesAntineoplastic and Immunomodulating AgentsComplement 5a Receptor Antagonist +22
Target Protein:
C5a anaphylatoxin chemotactic receptor 1
Waktu ParuhA single 30 mg dose…
Vol. DistribusiAvacopan has an app…
KlirensAvacopan has an est…
Genetik -
Avadomide DB14857
small molecule | CAS: 1015474-32-4

Avadomide is under investigation in clinical trial NCT02031419 (Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma).

Kategori:
Heterocyclic Compounds, Fused-RingPiperidinesQuinazolines
Target Protein:
Protein cereblon
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Avalglucosidase alfa Approved DB16099
biotech | CAS: 1802558-87-7

Avalglucosidase alfa, or NeoGAA, is a drug for enzyme replacement therapy specifically designed for Pompe disease, a rare inherited neuromuscular disorder caused by the deficiency of the alpha-glucosidase (GAA) enzyme. GAA is an essential enzyme that hydrolyz…

Kategori:
Alimentary Tract and MetabolismEnzyme Replacement TherapyEnzymes +2
Target Protein:
Cation-independent mannose-6-phosphate receptor
Waktu ParuhThe mean avalglucos…
Vol. DistribusiThe volume of distr…
KlirensThe mean avalglucos…
Genetik -
biotech | CAS: 2227000-30-6

Deskripsi belum tersedia.

Kategori:
Adeno-associated Viral Vector Therapies
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Avanafil Approved DB06237
small molecule | CAS: 330784-47-9

Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity th…

Kategori:
BCRP/ABCG2 InhibitorsCytochrome P-450 CYP2C9 SubstratesCytochrome P-450 CYP3A Substrates +9
Target Protein:
cGMP-specific 3',5'-cyclic phosphodiesterase
Waktu ParuhStudies have demons…
Vol. DistribusiThe apparent volume…
Klirens-
Genetik -
Avapritinib Approved DB15233
small molecule | CAS: 1703793-34-3

Avapritinib, or BLU-285,[A189327] is a selective tyrosine kinase inhibitor of KIT and platelet derived growth factor receptor alpha indicated for the treatment of unresectable, metastatic gastrointestinal stromal tumors and advanced systemic mastocytosis.[A18…

Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 Inhibitors +17
Target Protein:
Platelet-derived growth factor receptor alphaMast/stem cell growth factor receptor Kit
Waktu ParuhThe half life of av…
Vol. DistribusiThe mean apparent v…
KlirensThe mean apparent o…
Genetik -
Avasopasem DB18481
small molecule

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 435327-40-5

Avasopasem manganese, also known as GC4419, is a highly-selective small molecule mimetic of superoxide dismutase (SOD) being investigated for the reduction of radiation-induced severe oral mucositis.[L27246, L27256] This drug has potential application for rad…

Kategori:
AntioxidantsFree Radical Scavengers
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Avatrombopag Approved DB11995
small molecule | CAS: 570406-98-3

Avatrombopag (_Doptelet_), is an orally administered, small molecule thrombopoietin receptor (c-Mpl) agonist that increases platelet number without increasing platelet activation,[A33097,L2824] thereby decreasing the need for blood transfusions.[L2824] Patien…

Kategori:
BCRP/ABCG2 InhibitorsBlood and Blood Forming OrgansCytochrome P-450 CYP2C8 Inducers +14
Target Protein:
Thrombopoietin receptor
Waktu ParuhThe mean plasma eli…
Vol. DistribusiAvatrombopag has an…
KlirensThe mean (%CV) of t…
Genetik -
AVE-2865 DB07396
small molecule | CAS: 648917-13-9

Deskripsi belum tersedia.

Target Protein:
Glycogen phosphorylase, liver form
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Avelumab Approved DB11945
biotech | CAS: 1537032-82-8

Avelumab is a human IgG1 lambda monoclonal antibody that binds programmed cell death ligand-1 (PD-L1) to block its interaction with its receptors found on T cells and antigen-presenting cells.[A261496] Avelumab was first approved by the FDA on March 23, 2017.…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +19
Target Protein:
Programmed cell death 1 ligand 1
Waktu ParuhThe terminal half-l…
Vol. DistribusiThe geometric mean …
KlirensThe total systemic …
Genetik -
Avena sativa pollen Approved DB10377
biotech

Avena sativa pollen is the pollen of the Avena sativa plant. Avena sativa pollen is mainly used in allergenic testing.

Kategori:
Cell-mediated ImmunityIncreased Histamine ReleaseIncreased IgG Production +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Avenanthramides DB14743
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Avenciguat DB18882
small molecule | CAS: 1579514-06-9

Avenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blo…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 2401–2450 dari 11778
Sebelumnya Halaman 49 / 236 Berikutnya